Hensify

WIPO WIPO 2017

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark Hensify was filed as Figurative mark on 08/03/2017 at the World Intellectual Property Organization.

Logodesign (Wiener Klassifikation)

#Surfaces or backgrounds covered with repeated geometrical figures, figurative elements or inscriptions #Other polygons #Colours #Surfaces or backgrounds covered with repeated geometrical figures or designs #One polygon #Polygons containing one or more triangles or lines forming an angle (specify the content) #Three predominant colours

Trademark Details Last update: September 28, 2022

Trademark form Figurative mark
File reference 1372035
Register number 4337957
Countries Australia Bahrain em Israel India Japan South Korea Mexico Norway New Zealand Oman Philippines Singapore Turkmenistan Tunisia Turkey United States of America (USA) Albania Azerbaijan Switzerland China Algeria Egypt Iran Kyrgyzstan Kazakhstan Morocco Monaco Moldova Macedonia Serbia Russia Tajikistan Ukraine Vietnam
Base trademark FR No. 4337957, June 9, 2017
Application date August 3, 2017
Expiration date August 3, 2027

Trademark owner

60 RUE DE WATTIGNIES
F-75012 PARIS
FR

Trademark representatives

78 avenue Raymond Poincaré F-75116 PARIS FR

goods and services

05 Pharmaceutical products, namely agents for tumor treatment for use only in relation to radiotherapy; medicines for human use for use only in relation to radiotherapy for cancer treatment; healthcare products, namely pharmaceutical products for cancer treatment for use only in relation to radiotherapy; drugs for medical use for cancer treatment for use only in relation to radiotherapy; preparations for medical use for use only in relation to radiotherapy, particularly for tumor treatment; radiological contrast substances for medical use; chemical reagents for medical use for use only in relation to radiotherapy for cancer treatment; medical preparations for medical or pharmaceutical use consisting of medication delivery agents in the form of tablets and capsules for cancer treatment for use only in relation to radiotherapy; chemical-pharmaceutical products consisting in tablets or injectable products for cancer treatment for use only in relation to radiotherapy; diagnostic biomarking reagents for medical use for use only in relation to radiotherapy
10 Diagnostic apparatus for medical use, namely X-ray apparatus for medical use; radiology screens for medical use

Trademark history

Date Document number Area Entry
September 26, 2022 2022/39 Gaz CN RAW: Rule 18ter(4) all goods and services protected
May 6, 2019 2019/19 Gaz TM Rejection
April 26, 2019 2019/18 Gaz KR RAW: Rule 18ter(2)(ii) GP following a provisional refusal
November 19, 2018 2018/48 Gaz KG Rejection
November 8, 2018 2018/46 Gaz TR Rejection
November 4, 2018 2018/45 Gaz IL Rejection
October 10, 2018 2018/41 Gaz MX Rejection
October 9, 2018 2018/41 Gaz UA Rejection
September 25, 2018 2018/39 Gaz TJ Rejection
September 24, 2018 2018/39 Gaz CH Rejection
September 6, 2018 2018/36 Gaz MD Rejection
September 5, 2018 2018/38 Gaz OM RAW: Rule 18ter(2)(i) GP following a provisional refusal
August 27, 2018 2018/36 Gaz CN Rejection
August 23, 2018 2018/34 Gaz RS Rejection
August 17, 2018 2018/34 Gaz NO Rejection
August 12, 2018 2018/33 Gaz DZ Rejection
July 17, 2018 2018/32 Gaz OM Rejection
July 10, 2018 2018/29 Gaz US RAW: Rule 18ter(2)(i) GP following a provisional refusal
July 6, 2018 2018/28 Gaz KR Rejection
June 22, 2018 2018/28 Gaz KZ Rejection
June 15, 2018 2018/24 Gaz SG Rejection
June 13, 2018 2018/24 Gaz PH Rejection
May 31, 2018 2018/22 Gaz JP Rejection
May 16, 2018 2018/21 Gaz RU Rejection
March 28, 2018 2018/13 Gaz EM Rejection
March 26, 2018 2018/13 Gaz IN Rejection
March 1, 2018 2018/9 Gaz AU Rejection
February 27, 2018 2018/9 Gaz NZ Rejection
January 2, 2018 2018/1 Gaz MC Rejection
November 17, 2017 2017/47 Gaz US Rejection
August 3, 2017 2017/41 Gaz FR Registration

ID: 141372035